1. Home
  2. GKOS vs CROX Comparison

GKOS vs CROX Comparison

Compare GKOS & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CROX
  • Stock Information
  • Founded
  • GKOS 1998
  • CROX 1999
  • Country
  • GKOS United States
  • CROX United States
  • Employees
  • GKOS N/A
  • CROX N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CROX Shoe Manufacturing
  • Sector
  • GKOS Health Care
  • CROX Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • CROX Nasdaq
  • Market Cap
  • GKOS 5.4B
  • CROX 5.6B
  • IPO Year
  • GKOS 2015
  • CROX 2006
  • Fundamental
  • Price
  • GKOS $82.38
  • CROX $78.99
  • Analyst Decision
  • GKOS Strong Buy
  • CROX Buy
  • Analyst Count
  • GKOS 12
  • CROX 12
  • Target Price
  • GKOS $128.58
  • CROX $105.18
  • AVG Volume (30 Days)
  • GKOS 698.2K
  • CROX 1.7M
  • Earning Date
  • GKOS 11-03-2025
  • CROX 10-28-2025
  • Dividend Yield
  • GKOS N/A
  • CROX N/A
  • EPS Growth
  • GKOS N/A
  • CROX N/A
  • EPS
  • GKOS N/A
  • CROX 4.12
  • Revenue
  • GKOS $432,953,000.00
  • CROX $4,138,679,000.00
  • Revenue This Year
  • GKOS $28.79
  • CROX N/A
  • Revenue Next Year
  • GKOS $25.65
  • CROX $0.86
  • P/E Ratio
  • GKOS N/A
  • CROX $19.01
  • Revenue Growth
  • GKOS 26.70
  • CROX 2.04
  • 52 Week Low
  • GKOS $77.10
  • CROX $73.76
  • 52 Week High
  • GKOS $163.71
  • CROX $151.13
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 35.40
  • CROX 37.20
  • Support Level
  • GKOS $80.52
  • CROX $75.74
  • Resistance Level
  • GKOS $95.32
  • CROX $90.06
  • Average True Range (ATR)
  • GKOS 2.82
  • CROX 3.24
  • MACD
  • GKOS -1.23
  • CROX -0.42
  • Stochastic Oscillator
  • GKOS 11.29
  • CROX 20.45

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CROX Crocs Inc.

Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company are the United States and other Countries.

Share on Social Networks: